Interactions between 2'-fluoro-(carbamoylpyridinyl)deschloroepibatidine analogues and acetylcholine-binding protein inform on potent antagonist activity against nicotinic receptors
AB [auth F] AC [auth I] BA [auth C] BB [auth F] BC [auth I]
AB [auth F], AC [auth I], BA [auth C], BB [auth F], BC [auth I], CA [auth C], CB [auth F], CC [auth I], DA [auth C], DB [auth F], EA [auth C], EB [auth F], FA [auth C], FC [auth J], GA [auth C], GC [auth J], HA [auth C], HB [auth G], HC [auth J], IB [auth G], IC [auth J], JB [auth G], JC [auth J], KA [auth D], KB [auth G], KC [auth J], L [auth A], LA [auth D], LB [auth G], M [auth A], MA [auth D], MB [auth G], N [auth A], NA [auth D], O [auth A], OA [auth D], P [auth A], PA [auth D], PB [auth H], Q [auth A], QB [auth H], RB [auth H], SA [auth E], SB [auth H], T [auth B], TA [auth E], TB [auth H], U [auth B], UA [auth E], UB [auth H], V [auth B], VA [auth E], W [auth B], WA [auth E], X [auth B], XA [auth E], XB [auth I], Y [auth B], YB [auth I], ZB [auth I]